Forbes A P, Lake J R, Bloch K J
Clin Exp Immunol. 1975 Dec;22(3):426-30.
An anti-kidney antibody was demonstrated by the indirect immunofluorescence method in the serum of patients with primary tumours of the liver or kidney. The distribution of fluorescence in rabbit kidney was consistent with that of antibody to collecting ducts. The anti-collecting duct antibody (anti-CDA) could be absorbed from serum by normal adult rabbit or human kidney tissue and by one of three specimens of renal-cell carcinoma tissue. Anti-CDA differed from anti-mitochondrial antibodies and from anti-liver/kidney microsomal antibody in the pattern of fluorescent staining obtained with rabbit kidney. Two-hundred sera from patients with cancer and other diseases and forty-three from healthy hospital personnel were tested for anti-CDA. Eleven of the twenty-five positive sera were from patients with primary cancer of the liver or urinary tract, and all but six of the remainder were from patients with tumours involving the liver or with liver disorders that may be associated with nodular hyperplasia or tumour.
通过间接免疫荧光法在原发性肝癌或肾癌患者血清中证实了一种抗肾抗体。兔肾中荧光的分布与抗集合管抗体的分布一致。抗集合管抗体(anti-CDA)可被正常成年兔或人肾组织以及三种肾细胞癌组织标本之一从血清中吸收。在兔肾获得的荧光染色模式方面,抗CDA不同于抗线粒体抗体和抗肝肾微粒体抗体。对200份癌症和其他疾病患者的血清以及43份医院健康工作人员的血清进行了抗CDA检测。25份阳性血清中有11份来自原发性肝癌或泌尿系统癌症患者,其余的除6份外均来自患有累及肝脏的肿瘤或可能与结节性增生或肿瘤相关的肝脏疾病的患者。